Using AI to improve heart disease management in rural Australia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial aims to evaluate the effectiveness of artificial intelligence-guided echocardiography for the management of heart failure and valvular heart disease in rural and remote Australia. Given the geographic disparities in access to echocardiography, the study will utilize AI to optimize image acquisition and facilitate remote interpretation. Participants aged 40 and older with cardiovascular risk factors will be recruited through community outreach at multiple sites. The goal is to enhance early detection and management of heart conditions, potentially reducing hospital admissions and improving patient quality of life.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \>45 years
* eligible for Medicare
* exercise intolerance or cardiovascular (CV) risk factors

Exclusion Criteria:

* Known HF or HVD
* situations where cardio-protection is already indicated (eg. known CAD)
* comorbid conditions with life expectancy \<2 years
* inability to provide written informed consent

Where it's running

• Alice Springs Hospital
  Alice Springs, Northern Territory, Australia Recruiting

Study contacts

• Principal investigator: Tom Marwick, MBBS, PhD — Baker Heart and Diabetes Institute
• Study coordinator: Tom Marwick, MBBS, PhD
• Email: tom.marwick@baker.edu.au
• Phone: +61385321550

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Characterizing patients and outcomes in severe tricuspid regurgitation

  This study looks at people with severe tricuspid regurgitation to see who can get a new heart valve treatment and how well it works for them.

  Recruiting Medical University of Warsaw · Warsaw, Masovian Voivodeship · NCT06838611

• Using Apple Watch data to predict heart failure outcomes

  This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.

  Recruiting University Medical Center Goettingen · Goettigen, Lower Saxony · NCT06819618

• Comparing Aortix Device to Diuretics for Acute Heart Failure

  This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.

  Recruiting at 33 sites Procyrion · Phoenix, Arizona and 49 other locations · NCT05677100

• Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS

  Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.

  Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital · Beijing · NCT07912086

• Tailored digital support to cut sedentary time in long-term cardiac rehab

  In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.

  Recruiting University of Lisbon · Lisbon, Lisbon District · NCT07910812

• NT-proBNP–guided heart failure screening for people 65+ in rural China

  This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.

  Recruiting Jiangsu Taizhou People's Hospital · Nanjing · NCT07885488

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.